Alendronate Sodium
NDC 70954-264, Alendronate Sodium, solution, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-264
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214512
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-264 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALENDRONATE SODIUM70 mg/75mL
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-264-10 | 70954026410 | 4 BOTTLE in 1 CARTON (70954-264-10) / 75 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/81589178-10c9-4806-91eb-54e638d35b8dNADAC price for package 70954026410
GET /v1/drugs/nadac/70954026410
Use it
Look up 70954-264 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-264 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-264. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.